About
Generics
Areas of Focus
Categories
Generic Drug
Clinical Trials (4)
View allTotal Trials
4
As Lead Sponsor
2
As Collaborator
2
Total Enrollment
24,331
By Phase
PHASE2: 2NA: 1
By Status
WITHDRAWN: 1TERMINATED: 1COMPLETED: 1RECRUITING: 1
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
1988
1989
1990
1991
1992
1993
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
2033
2034
2035
2036
2037
2038
2039
2040
2041
2042
2043
2044
2045
2046
2047
2048
2049
2050
2051
2052
2053
2054
2055
2056
2057
2058
2059
2060
2061
2062
2063
2064
2065
2066
2067
2068
2069
2070
2071
2072
2073
2074
2075
2076
2077
2078
2079
2080
2081
2082
2083
2084
2085
2086
2087
2088
2089
2090
2091
2092
2093
2094
2095
2096
2097
2098
2099
2100
Today
Hover over trial bars to see details
Recent Trials
NCT04536090Collaborator
Study of Isoquercetin (IQC-950AN) Plus Standard of Care Versus Standard of Care Only for the Treatment of COVID-19
PHASE2Withdrawn
Started: Jan 31, 2022 · Completed: Jun 30, 2023
NCT04046328Lead Sponsor
Efficacy, Safety and Tolerability of Enteric-Coated Cholestyramine Capsules for Adult Short Bowel Syndrome
PHASE2Terminated
13 participants
Started: Oct 15, 2019 · Completed: Dec 22, 2021
NCT03062787Lead Sponsor
Early Effect of Cingal® Compared to Monovisc® in Patients With Osteoarthritis of the Knee
NACompleted
60 participants
Started: Apr 5, 2017 · Completed: Oct 25, 2017
NCT00404989Collaborator
Antiretroviral Pregnancy Registry (APR): Multi-sponsor Registry to Detect Any Major Teratogenic Effect Involving Any of the Registry Drugs When Administered to Pregnant People.
N/ARecruiting
24,258 participants
Started: Jan 31, 1989 · Completed: Jan 31, 2099
Locations (1)
Headquarters
Montréal, QC, Canada
Map
Loading map...